Facts
as of Nov 16, 2026
Vera Therapeutics is pursuing truth in science to transform medicine in autoimmune diseases, starting with the kidney. Explore our science, patient focus, and career opportunities.
It is hiring: 10 open roles, 3 of them posted in the last 30 days.
- Employees
- 51-200estimated range
- Listing
- NASDAQ: VERA
- Open roles
- 10Alion job postings
- Website
- veratx.com
As of Nov 16, 2026, Alion lists 10 open roles at Vera Therapeutics. The median pay stated in its open roles is $210k, across 10 postings that state pay.
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake
What the registers and the postings say about this employer.
Postings are real
Alion truth index: B
75/100
Ghost roles
re-checked against its careers site
0%
Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Hiring steadily, with new roles every week.
Biotech is the largest family, 30 of open roles.
3Posted in 30 days30% of open roles are fresh
100%Remote roles10 of 10
1Hiring offices
Alion signals0-100
Demand18
Pay29
Your chance52
How badly they need people, whether they pay, how realistic getting in is.
Open roles over time−100%
Sep 21This week
Open roles a week: 6 then, 0 now
Are the postings real?
B
75 / 100Vera Therapeutics scores B on the Alion truth index (A is best, E worst), measured over 3 open roles re-checked against its own hiring board: 0% look like ghost listings, 100% have gone stale and 0% are the same role posted again.
Ghost roles0%
Gone stale100%
Reposted0%
Where the openings areshare of open roles · trend
Biotech30▲
Operations20▼
Analytics10▲
Legal10▲
Marketing10▼
Sales10▼
Degree asked
Bachelor's Degree 56%Master's Degree 22%Doctoral Degree (PhD) 22%
Experience asked: 9.1 years on average, in 10 postings. 9 postings state a degree.
Benefits named in postingsshare of open roles
Equity10100%
Vision insurance10100%
Flexible time off10100%
401k plan10100%
Visa sponsorship: none statedRelocation: none stated
Source: the company's careers site, read by Alion several times a day; market medians from all open roles of the same family
What its postings pay, by level.
$250kMedian
$170k – $400kTypical rangeUSD a year
$400kHighest paying roleVice President, Commercial Manufacturing Operations
Source: the pay stated in the company's postings, normalised to USD a year
Named in the work visa registers of United States.
3 ▲ 50%H-1B filings in 12 months
$218kMedian offered salary
0Open roles in United States
In the register as Vera Therapeutics, Inc., Brisbane, CA
Other sponsors in the same field
Alert me
US Department of Labor · latest filing Dec 18, 2025
Footprint
Hiring in 1 city in 1 country.
1Cities
1Countries
BrisbaneBusiest site
Source: office addresses in postings and company registers
Technologies named in job postings at Vera Therapeutics over the last 12 months, by layer, with the share of postings for each.
8Technologies in use
6Postings analysed
50/100Stack modernity
Sign in to see how your skills match this stackSign In
Source: the technologies named in the company's postings and on its site
Newsroom
Sep 152026
News · Blockonomi
Vera Therapeutics (VERA) stock jumped 4% after two-year ORIGIN3 trial data showed Trutakna slowed kidney decline to normal aging rates in IgAN patients.
Sep 152026
News · YahooFinance
Vera Therapeutics (NASDAQ:VERA) shares rose 13% on Tuesday after the company reported that TRUTAKNA (atacicept-vymj) met all prespecified endpoints in the final efficacy analysis…
Sep 152026
News · markets.businessinsider.com
TRUTAKNA, the first and only FDA-approved BAFF and APRIL inhibitor, met all prespecified endpoints, including unprecedented placebo-adjusted estim...
Sep 52026
News · markets.businessinsider.com
BRISBANE, Calif., Sept. 04, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that, on September 1, 2026, the Comp...
Jul 82026
Press release · The Globe and Mail
Detailed price information for Vera Therapeutics Inc Cl A (VERA-Q) from The Globe and Mail including charting and trades.
Sources: the outlets named on each headline, each story once